Neuromuscular disorders as emergencies in the intensive care setting - A retrospective cohort study on predictors of clinical outcome

Neuromuscular disorders as emergencies in the intensive care setting - A retrospective cohort study on predictors of clinical outcome - Emergencies in neuromuscular disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034372

Enrollment

300

Registered

2024-07-08

Start date

2024-07-15

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic inflammatory myopathies myasthenia gravis Rhabdomyolysis Guillian Bare Syndrome

Interventions

Group 1: Patients who are being treated in a neurological intensive care unit (ICU) or intermediate care unit (IMC) due to their neuromuscular disease

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Treatment on a neurological IMC / ICU Treatment is due to the neuromuscular disease and specific complications Treatment is due to an exacerbation of the underlying disease Treatment due to fulminant onset of the underlying neuromuscular disease

Exclusion criteria

Exclusion criteria: Treatment is due to another cause unrelated to the underlying disease

Design outcomes

Primary

Measure	Time frame
Identification of the most important predictors of clinical outcome	—

Secondary

Measure	Time frame
Frequency of the different neuromuscular diseases Duration and necessity of ventilation Invasiveness of ventilation Complication rate Duration of intensive care stay Mortality rate Kind of escalation therapy	—

Countries

Germany

Contacts

Public ContactJana Zschüntzsch

Universitätsmedizin Göttingen, Klinik für Neurologie

j.zschuentzsch@med.uni-goettingen.de+49 551 3965683

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026